- Home
- INOD vs TSHA Comparison
INOD vs TSHA Comparison
Compare INOD & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INOD
- TSHA
- Stock Information
- Founded
- INOD 1988
- TSHA 2019
- Country
- INOD United States
- TSHA United States
- Employees
- INOD N/A
- TSHA N/A
- Industry
- INOD EDP Services
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- INOD Technology
- TSHA Health Care
- Exchange
- INOD Nasdaq
- TSHA Nasdaq
- Market Cap
- INOD 1.2B
- TSHA 403.7M
- IPO Year
- INOD 1993
- TSHA 2020
- Fundamental
- Price
- INOD $33.95
- TSHA $1.62
- Analyst Decision
- INOD Strong Buy
- TSHA Strong Buy
- Analyst Count
- INOD 4
- TSHA 8
- Target Price
- INOD $36.50
- TSHA $6.63
- AVG Volume (30 Days)
- INOD 1.7M
- TSHA 2.5M
- Earning Date
- INOD 02-20-2025
- TSHA 11-13-2024
- Dividend Yield
- INOD N/A
- TSHA N/A
- EPS Growth
- INOD N/A
- TSHA N/A
- EPS
- INOD 0.62
- TSHA N/A
- Revenue
- INOD $137,393,000.00
- TSHA $9,915,000.00
- Revenue This Year
- INOD $93.11
- TSHA N/A
- Revenue Next Year
- INOD $34.30
- TSHA N/A
- P/E Ratio
- INOD $54.63
- TSHA N/A
- Revenue Growth
- INOD 71.66
- TSHA N/A
- 52 Week Low
- INOD $5.46
- TSHA $1.19
- 52 Week High
- INOD $55.17
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- INOD 40.92
- TSHA 36.69
- Support Level
- INOD $32.54
- TSHA $1.56
- Resistance Level
- INOD $46.69
- TSHA $2.07
- Average True Range (ATR)
- INOD 3.43
- TSHA 0.15
- MACD
- INOD -1.22
- TSHA -0.01
- Stochastic Oscillator
- INOD 9.96
- TSHA 11.76
About INOD Innodata Inc.
Innodata Inc is a digital services and solutions company. It provides technology and services to information products and online retail destinations. The company has three operating segments: Digital data solutions, Synodex, and Agility. It serves publishers, media and information companies, digital retailers, banks, insurance companies, government agencies, and other industries. Geographically, it operates in the United States, United Kingdom, Netherlands, Canada, and Europe.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.